Yoshiaki Usui et al.: Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. In: New England Journal of Medicine. Band 388, Nr. 13, 2023, S. 1181–1190, doi:10.1056/NEJMoa2211807. BRCA-Netzwerk: Magenkrebs.
J. M. Noto, J. A. Gaddy u. a.: Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. In: The Journal of clinical investigation. Band 123, Nummer 1, Januar 2013, S. 479–492, ISSN1558-8238. doi:10.1172/JCI64373. PMID 23257361. PMC 3533289 (freier Volltext).
Ke Ma, Zulqarnain Baloch, Ting-Ting He, Xueshan Xia: Alcohol Consumption and Gastric Cancer Risk: A Meta-Analysis. In: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. Band23, 14. Januar 2017, ISSN1234-1010, S.238–246, doi:10.12659/MSM.899423, PMID 28087989, PMC 5256369 (freier Volltext).
Yoshiaki Usui et al.: Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. In: New England Journal of Medicine. Band 388, Nr. 13, 2023, S. 1181–1190, doi:10.1056/NEJMoa2211807. BRCA-Netzwerk: Magenkrebs.
The Cancer Genome Atlas Research Group: Comprehensive molecular characterization of gastric adenocarcinoma. In: Nature 2014; Band 513: S. 202–209 doi:10.1038/nature13480
D. Cunningham, W. H. Allum, S. P. Stenning, J. N. Thompson, C. J. Van de Velde, M. Nicolson, J. H. Scarffe, F. J. Lofts, S. J. Falk, T. J. Iveson, D. B. Smith, R. E. Langley, M. Verma, S. Weeden, Y. J. Chua, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. In: N Engl J Med. 2006;355(1), S. 11–20. PMID 16822992. doi:10.1056/NEJMoa055531
M. Ychou, V. Boige, J. P. Pignon, T. Conroy, O. Bouché, G. Lebreton, M. Ducourtieux, L. Bedenne, J. M. Fabre, B. Saint-Aubert, J. Genève, P. Lasser, P. Rougier: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. In: J Clin Oncol. 2011;29(13), S. 1715–1721. PMID 21444866. doi:10.1200/JCO.2010.33.0597
Y. J. Bang, E. Van-Cutsem, A. Feyereislova, H. C. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, J. Hill, M. Lehle, J. Rüschoff, Y. K. Kang; ToGA Trial Investigators: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. In: Lancet. 2010;376(9742), S. 687–697. PMID 20728210. doi:10.1016/S0140-6736(10)61121-X.
mmw.de
Abgewandelt zitiert nach: Was schützt vor Krebs und Diabetes? In: MMW-Fortschr. Med. Nr. 24 / 2007 (149. Jg.), S. 16, dort zitiert nach EPIC-Symposium, Berlin, 25. April 2007.
nih.gov
ncbi.nlm.nih.gov
J. M. Noto, J. A. Gaddy u. a.: Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. In: The Journal of clinical investigation. Band 123, Nummer 1, Januar 2013, S. 479–492, ISSN1558-8238. doi:10.1172/JCI64373. PMID 23257361. PMC 3533289 (freier Volltext).
Ke Ma, Zulqarnain Baloch, Ting-Ting He, Xueshan Xia: Alcohol Consumption and Gastric Cancer Risk: A Meta-Analysis. In: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. Band23, 14. Januar 2017, ISSN1234-1010, S.238–246, doi:10.12659/MSM.899423, PMID 28087989, PMC 5256369 (freier Volltext).
D. Cunningham, W. H. Allum, S. P. Stenning, J. N. Thompson, C. J. Van de Velde, M. Nicolson, J. H. Scarffe, F. J. Lofts, S. J. Falk, T. J. Iveson, D. B. Smith, R. E. Langley, M. Verma, S. Weeden, Y. J. Chua, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. In: N Engl J Med. 2006;355(1), S. 11–20. PMID 16822992. doi:10.1056/NEJMoa055531
M. Ychou, V. Boige, J. P. Pignon, T. Conroy, O. Bouché, G. Lebreton, M. Ducourtieux, L. Bedenne, J. M. Fabre, B. Saint-Aubert, J. Genève, P. Lasser, P. Rougier: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. In: J Clin Oncol. 2011;29(13), S. 1715–1721. PMID 21444866. doi:10.1200/JCO.2010.33.0597
Y. J. Bang, E. Van-Cutsem, A. Feyereislova, H. C. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, J. Hill, M. Lehle, J. Rüschoff, Y. K. Kang; ToGA Trial Investigators: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. In: Lancet. 2010;376(9742), S. 687–697. PMID 20728210. doi:10.1016/S0140-6736(10)61121-X.
J. M. Noto, J. A. Gaddy u. a.: Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. In: The Journal of clinical investigation. Band 123, Nummer 1, Januar 2013, S. 479–492, ISSN1558-8238. doi:10.1172/JCI64373. PMID 23257361. PMC 3533289 (freier Volltext).
Ke Ma, Zulqarnain Baloch, Ting-Ting He, Xueshan Xia: Alcohol Consumption and Gastric Cancer Risk: A Meta-Analysis. In: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. Band23, 14. Januar 2017, ISSN1234-1010, S.238–246, doi:10.12659/MSM.899423, PMID 28087989, PMC 5256369 (freier Volltext).